NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $223,000 | -14.2% | 2,100 | -51.7% | 0.01% | -8.3% |
| Q4 2017 | $260,000 | -5.8% | 4,350 | -62.2% | 0.01% | 0.0% |
| Q3 2017 | $276,000 | -43.6% | 11,500 | -54.0% | 0.01% | -42.9% |
| Q2 2017 | $489,000 | -16.7% | 25,000 | 0.0% | 0.02% | -30.0% |
| Q1 2017 | $587,000 | -52.2% | 25,000 | -75.0% | 0.03% | -48.3% |
| Q4 2016 | $1,227,000 | – | 100,000 | – | 0.06% | – |
| Q3 2013 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |